Switch to:

Fate Therapeutics EV-to-EBIT

: -31.49 (As of Today)
View and export this data going back to 2013. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fate Therapeutics's Enterprise Value is $3,669.25 Mil. Fate Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-116.54 Mil. Therefore, Fate Therapeutics's EV-to-EBIT for today is -31.49.

NAS:FATE' s EV-to-EBIT Range Over the Past 10 Years
Min: -31.75   Med: -4   Max: 0.1
Current: -31.5

-31.75
0.1

During the past 9 years, the highest EV-to-EBIT of Fate Therapeutics was 0.10. The lowest was -31.75. And the median was -4.00.

NAS:FATE's EV-to-EBIT is ranked lower than
99.99% of the 240 Companies
in the Biotechnology industry.

( Industry Median: 33.11 vs. NAS:FATE: -31.50 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Fate Therapeutics's Enterprise Value for the quarter that ended in Jun. 2020 was $2,525.82 Mil. Fate Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-116.54 Mil. Fate Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was -4.61%.


Fate Therapeutics EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Fate Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -0.71 -5.65 -9.92 -13.36

Fate Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.22 -10.80 -13.36 -13.97 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Fate Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Fate Therapeutics's EV-to-EBIT falls into.



Fate Therapeutics EV-to-EBIT Calculation

Fate Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3669.252/-116.537
=-31.49

Fate Therapeutics's current Enterprise Value is $3,669.25 Mil.
Fate Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was -26.209 (Sep. 2019 ) + -27.764 (Dec. 2019 ) + -34.492 (Mar. 2020 ) + -28.072 (Jun. 2020 ) = $-116.54 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Fate Therapeutics  (NAS:FATE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Fate Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 ) =EBIT / Enterprise Value (Q: Jun. 2020 )
=-116.537/2525.815482
=-4.61 %

Fate Therapeutics's Enterprise Value for the quarter that ended in Jun. 2020 was $2,525.82 Mil.
Fate Therapeutics's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was -26.209 (Sep. 2019 ) + -27.764 (Dec. 2019 ) + -34.492 (Mar. 2020 ) + -28.072 (Jun. 2020 ) = $-116.54 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Fate Therapeutics EV-to-EBIT Related Terms


Fate Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)